Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.
2.

Chlamydia pneumoniae: An Etiologic Agent for Late-Onset Dementia.

Balin BJ, Hammond CJ, Little CS, Hingley ST, Al-Atrache Z, Appelt DM, Whittum-Hudson JA, Hudson AP.

Front Aging Neurosci. 2018 Oct 9;10:302. doi: 10.3389/fnagi.2018.00302. eCollection 2018. Review.

3.

Gliopathy of Demyelinating and Non-Demyelinating Strains of Mouse Hepatitis Virus.

Kenyon LC, Biswas K, Shindler KS, Nabar M, Stout M, Hingley ST, Grinspan JB, Das Sarma J.

Front Cell Neurosci. 2015 Dec 22;9:488. doi: 10.3389/fncel.2015.00488. eCollection 2015.

4.

Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in Alzheimer's disease.

Lim C, Hammond CJ, Hingley ST, Balin BJ.

J Neuroinflammation. 2014 Dec 24;11:217. doi: 10.1186/s12974-014-0217-0.

5.

Mechanisms of primary axonal damage in a viral model of multiple sclerosis.

Das Sarma J, Kenyon LC, Hingley ST, Shindler KS.

J Neurosci. 2009 Aug 19;29(33):10272-80. doi: 10.1523/JNEUROSCI.1975-09.2009.

6.

Experimental optic neuritis induced by a demyelinating strain of mouse hepatitis virus.

Shindler KS, Kenyon LC, Dutt M, Hingley ST, Das Sarma J.

J Virol. 2008 Sep;82(17):8882-6. doi: 10.1128/JVI.00920-08. Epub 2008 Jun 25.

7.

Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry.

Qiu Z, Hingley ST, Simmons G, Yu C, Das Sarma J, Bates P, Weiss SR.

J Virol. 2006 Jun;80(12):5768-76.

9.

The virulence of mouse hepatitis virus strain A59 is not dependent on efficient spike protein cleavage and cell-to-cell fusion.

Hingley ST, Leparc-Goffart I, Seo SH, Tsai JC, Weiss SR.

J Neurovirol. 2002 Oct;8(5):400-10.

10.

Role of the spike protein in murine coronavirus induced hepatitis: an in vivo study using targeted RNA recombination.

Navas S, Seo SH, Chua MM, Das Sarma J, Hingley ST, Lavi E, Weiss SR.

Adv Exp Med Biol. 2001;494:139-44. No abstract available.

PMID:
11774458
12.

Mouse hepatitis virus type-2 infection in mice: an experimental model system of acute meningitis and hepatitis.

Das Sarma J, Fu L, Hingley ST, Lavi E.

Exp Mol Pathol. 2001 Aug;71(1):1-12.

PMID:
11502093
13.

Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis.

Navas S, Seo SH, Chua MM, Das Sarma J, Lavi E, Hingley ST, Weiss SR.

J Virol. 2001 Mar;75(5):2452-7.

14.

Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism.

Leparc-Goffart I, Hingley ST, Chua MM, Phillips J, Lavi E, Weiss SR.

J Virol. 1998 Dec;72(12):9628-36.

15.

Protein phosphorylation associated with epipodophyllotoxin-induced apoptosis of lymphoid cells: role of a serine/threonine protein kinase.

Ye X, Mody NS, Hingley ST, Coffman FD, Cohen S, Fresa KL.

Clin Immunol Immunopathol. 1998 Nov;89(2):117-25.

PMID:
9787113
16.

The C12 mutant of MHV-A59 is very weakly demyelinating and has five amino acid substitutions restricted to the spike and replicase genes.

Leparc-Goffart I, Hingley ST, Jiang X, Chua MM, Lavi E, Weiss SR.

Adv Exp Med Biol. 1998;440:627-33.

PMID:
9782338
17.

The mouse hepatitis virus A59 spike protein is not cleaved in primary hepatocyte and glial cell cultures.

Hingley ST, Leparc-Goffart I, Weiss SR.

Adv Exp Med Biol. 1998;440:529-35.

PMID:
9782325
19.

Altered pathogenesis of a mutant of the murine coronavirus MHV-A59 is associated with a Q159L amino acid substitution in the spike protein.

Leparc-Goffart I, Hingley ST, Chua MM, Jiang X, Lavi E, Weiss SR.

Virology. 1997 Dec 8;239(1):1-10.

21.

Hepatitis mutants of mouse hepatitis virus strain A59.

Hingley ST, Gombold JL, Lavi E, Weiss SR.

Adv Exp Med Biol. 1995;380:577-82.

PMID:
8830545
22.

Genomic regions associated with neurotropism identified in MHV by RNA-RNA recombination.

Lavi E, Wang Q, Hingley ST, Weiss SR.

Adv Exp Med Biol. 1995;380:51-6.

PMID:
8830532
23.

MHV-A59 fusion mutants are attenuated and display altered hepatotropism.

Hingley ST, Gombold JL, Lavi E, Weiss SR.

Virology. 1994 Apr;200(1):1-10.

PMID:
8128613
24.
25.

Identification of peplomer cleavage site mutations arising during persistence of MHV-A59.

Gombold JL, Hingley ST, Weiss SR.

Adv Exp Med Biol. 1993;342:157-63.

PMID:
8209723
26.

The effect of rhamnolipid hemolysin of Pseudomonas aeruginosa on respiratory epithelium.

Hastie AT, Hingley ST, Higgins ML, Kueppers F.

Am Rev Respir Dis. 1987 Feb;135(2):513-4. No abstract available.

PMID:
3101561
27.

Disruption of respiratory cilia by proteases including those of Pseudomonas aeruginosa.

Hingley ST, Hastie AT, Kueppers F, Higgins ML.

Infect Immun. 1986 Nov;54(2):379-85.

28.

Effect of ciliostatic factors from Pseudomonas aeruginosa on rabbit respiratory cilia.

Hingley ST, Hastie AT, Kueppers F, Higgins ML, Weinbaum G, Shryock T.

Infect Immun. 1986 Jan;51(1):254-62.

29.

Rhamnolipid from Pseudomonas aeruginosa inactivates mammalian tracheal ciliary axonemes.

Hastie AT, Hingley ST, Higgins ML, Kueppers F, Shryock T.

Cell Motil Cytoskeleton. 1986;6(5):502-9.

PMID:
2947698
30.

Bacterial ciliostatic factors; effect on respiratory cilia.

Hingley ST, Hastie AT, Kueppers F, Higgins ML, Weinbaum G.

Eur J Respir Dis Suppl. 1986;146:291-3. No abstract available.

PMID:
2946599
31.

Isolation of cilia from porcine tracheal epithelium and extraction of dynein arms.

Hastie AT, Dicker DT, Hingley ST, Kueppers F, Higgins ML, Weinbaum G.

Cell Motil Cytoskeleton. 1986;6(1):25-34.

PMID:
2938744
32.

Protease production by Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Hastie AT, Hingley ST, Kueppers F, Higgins ML, Tannenbaum CS, Weinbaum G.

Infect Immun. 1983 May;40(2):506-13.

Supplemental Content

Loading ...
Support Center